Probi: Q2 2022: Solid quarter with exchange rate fueled growth
Important events during the second quarter
Net sales increased by 10% (-1% adjusted for currency effects) to SEK 175 m (158) in Q2 and am...
Below you will find current and archived press releases for your associated company. Navigate by selecting the year in the list below and click on the press release you want to read. Distribution takes place with a maximum of five minutes delay from press release.
Important events during the second quarter
Net sales increased by 10% (-1% adjusted for currency effects) to SEK 175 m (158) in Q2 and am...
Probi's report for the second quarter 2022 will be published on Friday, 15 July at 8.00 a.m. CET.
In conjunction with this, analysts, investors...
Flaggningsmeddelande i PROBI Aktiebolag
Anmälan om förvärv eller överlåtelse av finansiella instrument.
Emittent
...
On Probi's Annual General Meeting on 5 May 2022, the following was resolved:
The Annual General Meetin...
Important events during the first quarter
Net sales decreased by 10% (-16% adjusted for currency effects) to SEK 155 m (171).
The EB...
Probi's report for the first quarter 2022 will be published on Tuesday, 26 April at 8.00 a.m. CET.
In conjunction with this, analysts, investor...
By-product from Probi's manufacturing of probiotic dietary supplements is used in a new skin care product to be launched by Symrise in April 2022....
Probi's Annual Report and Sustainability Report for 2021 are now available on the company website, www.probi.com under Investor Relations: https:/...
Probi[®] has completed the first commercial production batches of a dairy-free Streptococcus salivarius BLIS K12 at its US manufacturing site. The...
The shareholders of Probi AB (publ), reg. no. 556417-7540, are hereby officially convened to the Annual General Meeting ("AGM") which will be held...
Significant events during the fourth quarter
Net sales decreased by 8% (-9% adjusted for currency effects) to SEK 170 m (185).
The E...
Probi's Year-End Report for 2021 will be published on Wednesday, 2 February at 8.00 a.m. CET.
In conjunction with this, analysts, investors and...